- Filed
- Mar 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 30, 2026 | 1.46M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 875.19K sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 385.65K sh |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$7.7M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$13.32M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $4.98M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $16.04M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $3.71M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $4.68M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $14.14M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $1.64M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $4.16M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $1.7M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $9.47M |
| Current Assets | FY 2025 · Dec 31, 2025 | $9.21M |
| Current Assets | FY 2025 · Dec 31, 2024 | $21.26M |
| Total Assets | FY 2025 · Dec 31, 2025 | $11.41M |
| Total Assets | FY 2025 · Dec 31, 2024 | $21.74M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$32.24 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$32.25 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$32.24 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$32.25 |
| Rd Expense | FY 2025 · Dec 31, 2025 | $1.39M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $1.49M |
| Net Income | FY 2025 · Dec 31, 2025 | −$21.09M |
| Net Income | FY 2025 · Dec 31, 2024 | −$1.76M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$10.46M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$19.38M |
| Gross Profit | FY 2025 · Dec 31, 2025 | −$956.16K |
| Gross Profit | FY 2025 · Dec 31, 2024 | −$6.59M |
| Stock Repurchased | FY 2025 · Dec 31, 2024 | $376.63K |
| Capex | FY 2025 · Dec 31, 2024 | $199.32K |
| Revenue | FY 2025 · Dec 31, 2024 | $63.78K |